NCT06489743View on ClinicalTrials.gov

Highlanders With High Altitude Pulmonary Hypertension (HAPH), 6 Minute Walk Distance (6MWD) Assessed at 3200m With and Without Supplemental Oxygen Therapy (SOT)

NANot yet recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions
High Altitude Pulmonary Hypertension
Interventions
OTHER

6-minute walk test (6MWT)

6-minute walk test (6MWT) will be performed according to clinical standards

Trial Locations (1)

Unknown

Aksay Medical Center, Aksay Plateau

All Listed Sponsors
lead

University of Zurich

OTHER

NCT06489743 - Highlanders With High Altitude Pulmonary Hypertension (HAPH), 6 Minute Walk Distance (6MWD) Assessed at 3200m With and Without Supplemental Oxygen Therapy (SOT) | Biotech Hunter | Biotech Hunter